Theratechnologies Stock Price To Earnings To Growth
| TH Stock | CAD 1.71 0.02 1.16% |
Theratechnologies fundamentals help investors to digest information that contributes to Theratechnologies' financial success or failures. It also enables traders to predict the movement of Theratechnologies Stock. The fundamental analysis module provides a way to measure Theratechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theratechnologies stock.
Theratechnologies | Price To Earnings To Growth |
Theratechnologies Company Price To Earnings To Growth Analysis
Theratechnologies' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Theratechnologies Price To Earnings To Growth | (199.00) X |
Most of Theratechnologies' fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theratechnologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Theratechnologies Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Theratechnologies is extremely important. It helps to project a fair market value of Theratechnologies Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Theratechnologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Theratechnologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Theratechnologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Theratechnologies Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Theratechnologies has a Price To Earnings To Growth of -199.0 times. This is 28128.17% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The price to earnings to growth for all Canada stocks is notably higher than that of the company.
Theratechnologies Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Theratechnologies' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics of similar companies.Theratechnologies is currently under evaluation in price to earnings to growth category among related companies.
Theratechnologies Current Valuation Drivers
We derive many important indicators used in calculating different scores of Theratechnologies from analyzing Theratechnologies' financial statements. These drivers represent accounts that assess Theratechnologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theratechnologies' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 713.9M | 1.2B | 830.7M | 41.9M | 37.7M | 35.8M | |
| Enterprise Value | 756.5M | 1.2B | 873.5M | 66.8M | 60.1M | 57.1M |
Theratechnologies Fundamentals
| Return On Equity | -11.17 | ||||
| Return On Asset | -0.0455 | ||||
| Profit Margin | (0.23) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 99.31 M | ||||
| Shares Outstanding | 45.98 M | ||||
| Shares Owned By Insiders | 6.28 % | ||||
| Shares Owned By Institutions | 50.90 % | ||||
| Number Of Shares Shorted | 15.6 K | ||||
| Price To Earning | (52.28) X | ||||
| Price To Book | 19.46 X | ||||
| Price To Sales | 1.11 X | ||||
| Revenue | 81.76 M | ||||
| Gross Profit | 56.22 M | ||||
| EBITDA | (2.94 M) | ||||
| Net Income | (23.96 M) | ||||
| Cash And Equivalents | 9.21 M | ||||
| Cash Per Share | 0.35 X | ||||
| Total Debt | 7.29 M | ||||
| Debt To Equity | 6.46 % | ||||
| Current Ratio | 1.90 X | ||||
| Book Value Per Share | (0.54) X | ||||
| Cash Flow From Operations | (5.68 M) | ||||
| Short Ratio | 1.15 X | ||||
| Earnings Per Share | (0.80) X | ||||
| Price To Earnings To Growth | (199.00) X | ||||
| Target Price | 6.42 | ||||
| Number Of Employees | 103 | ||||
| Beta | 1.81 | ||||
| Market Capitalization | 78.63 M | ||||
| Total Asset | 77.77 M | ||||
| Retained Earnings | (408.66 M) | ||||
| Working Capital | 16 M | ||||
| Current Asset | 34.42 M | ||||
| Current Liabilities | 16.85 M | ||||
| Net Asset | 77.77 M |
About Theratechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theratechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Theratechnologies Stock analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| CEOs Directory Screen CEOs from public companies around the world |